Viltepso
Active substance: Viltolarsen
INJECTION, SOLUTION · VILTOLARSEN 250 mg/1
United StatesActive
Marketing holder: NS Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- VILTOLARSEN · 250 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-7bb6-7501-8c25-02e6e5a10bec;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12097-5095-726c-976c-a1a15bb65f9c;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73292-011
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 73292-011 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73292-011 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73292-011 · Verified 2026-10-09 · open in source